Biogen
ID: 160844A biotechnology company with a focus on treatments for neurological and neurodegenerative diseases. It was founded in 1978 and has headquarters in Cambridge, Massachusetts.
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Wa**** Gi***** | - | - | - |
| Ke***** Mu**** (b********* | - | - | - |
| Ph***** Al*** Sh*** | - | - | - |
| Ch***** We******* | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Ge**** A. Sc***** | - | - |
Industries
Biogen is active in the following industries:
- Pharmaceutical industry
- Drug discovery
- Advanced Manufacturing
- Biomedical engineering
- Manufacturing
- Alzheimer's disease
- Biopharmaceutical
- Biologics
- Engineering
- Amyotrophic lateral sclerosis
- Generic drug
- Biosimilar
- Digital therapeutics
- Therapeutics
- Research and development
- Technology
- Brain-computer interface
- Biology
- Biotechnology
- Regenerative medicine
- Synthetic chemistry
- Neurodegenerative Disease
Subsidiaries
Biogen operates through the following subsidiaries:
